Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> ASTRAZENECA Latest News

OCT 16, 2014 - Huffington Post

A Must Read - Share

Obama Scores Big Win Against Tax-Dodging Deals

LONDON, Oct 16 (Reuters) - U.S. drugmaker AbbVie has pulled the plug on its plan to buy Dublin-based Shire , recommending shareholders vote against the proposed $55 billion takeover following new U.S. tax rules. Shire stands to be paid a break-up fee of about $1.64 billion, assuming AbbVie's shareholders follow the advice and reject the transaction. The reversal -- which ...

Tags: Obama Scores Big Win Against Tax-Dodging Deals,  Astrazeneca Latest News

OCT 15, 2014 - TheStreet

A Must Read - Share

AbbVie Backs Away From Shire Takeover After Tax Changes

Shares in rare diseases specialist Shire plc plunged in London on Wednesday after bidder AbbVie Inc. said it would reconsider its u32 billion ($50.9 billion) takeover agreement after a U.S. clampdown on M&A used for tax inversions. AbbVie had in July agreed to offer 2,444 pence in cash and 0.8960 of a new AbbVie share per share of the Dublin ...

Tags: AbbVie Backs Away From Shire Takeover After Tax Changes,  Astrazeneca Latest News

OCT 15, 2014 - TheStreet

A Must Read - Share

European Stocks Fall on Continued Worries Over Eurozone Economy

LONDON (The Deal) -- European stocks fell on Wednesday, failing to take their cue from a largely positive day in Asia as investors continued to worry about the outlook for the eurozone economy. Weak data and cuts in GDP growth forecasts for Germany and elsewhere have created panic about the prospect of another recession, which would also hammer the relatively ...

Tags: European Stocks Fall on Continued Worries Over Eurozone Economy,  Astrazeneca Latest News

OCT 14, 2014 - Business Insider

A Must Read - Share

AbbVie Says To Reconsider Recommendation For Shire Acquisition

(Reuters) - AbbVie Inc said it intends to reconsider its recommendation to its shareholders to vote in favor of the 32 billion pound ($54.7 billion) merger with Shire Plc due to the changing U.S. tax regulations.Chicago-based AbbVie, which makes top-selling arthritis drug Humira, is eager to buy Shire to reduce its U.S. tax bill by moving its tax base to ...

Tags: AbbVie Says To Reconsider Recommendation For Shire Acquisition,  Astrazeneca Latest News

OCT 13, 2014 - Zacks Investment Research

A Must Read - Share

Targacept's Nine-Year Association with AstraZeneca to End - Analyst Blog

Targacept (TRGT) announced that AstraZeneca (AZN) has terminated their nine-year old collaborative research and license agreement.

Tags: Targacept's Nine-Year Association with AstraZeneca to End - Analyst Blog,  Astrazeneca Latest News